Axatilimab Combined With Decitabine/Venetoclax for the Treatment of TP53-mutated AML
Clinical trial NCT07511062 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07511062
- Sponsor
- Northside Hospital, Inc.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-08-01
- Primary completion
- 2029-08-01
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.